Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Mesenchymal Neuroblastoma Cells Are Undetected by Current mRNA Marker Panels: The Development of a Specific Neuroblastoma Mesenchymal Minimal Residual Disease Panel.
van Wezel EM, van Zogchel LMJ, van Wijk J, Timmerman I, Vo NK, Zappeij-Kannegieter L, deCarolis B, Simon T, van Noesel MM, Molenaar JJ, van Groningen T, Versteeg R, Caron HN, van der Schoot CE, Koster J, van Nes J, Tytgat GAM. van Wezel EM, et al. Among authors: van groningen t. JCO Precis Oncol. 2019 Oct 3;3:PO.18.00413. doi: 10.1200/PO.18.00413. eCollection 2019. JCO Precis Oncol. 2019. PMID: 34036221 Free PMC article.
A NOTCH3 transcriptional module induces cell motility in neuroblastoma.
van Nes J, Chan A, van Groningen T, van Sluis P, Koster J, Versteeg R. van Nes J, et al. Among authors: van groningen t. Clin Cancer Res. 2013 Jul 1;19(13):3485-94. doi: 10.1158/1078-0432.CCR-12-3021. Epub 2013 May 6. Clin Cancer Res. 2013. PMID: 23649002
Neuroblastoma is composed of two super-enhancer-associated differentiation states.
van Groningen T, Koster J, Valentijn LJ, Zwijnenburg DA, Akogul N, Hasselt NE, Broekmans M, Haneveld F, Nowakowska NE, Bras J, van Noesel CJM, Jongejan A, van Kampen AH, Koster L, Baas F, van Dijk-Kerkhoven L, Huizer-Smit M, Lecca MC, Chan A, Lakeman A, Molenaar P, Volckmann R, Westerhout EM, Hamdi M, van Sluis PG, Ebus ME, Molenaar JJ, Tytgat GA, Westerman BA, van Nes J, Versteeg R. van Groningen T, et al. Nat Genet. 2017 Aug;49(8):1261-1266. doi: 10.1038/ng.3899. Epub 2017 Jun 26. Nat Genet. 2017. PMID: 28650485
Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors.
Westerhout EM, Hamdi M, Stroeken P, Nowakowska NE, Lakeman A, van Arkel J, Hasselt NE, Bleijlevens B, Akogul N, Haneveld F, Chan A, van Sluis P, Zwijnenburg D, Volckmann R, van Noesel CJM, Adameyko I, van Groningen T, Koster J, Valentijn LJ, van Nes J, Versteeg R. Westerhout EM, et al. Among authors: van groningen t. Cancer Res. 2022 Feb 1;82(3):484-496. doi: 10.1158/0008-5472.CAN-21-1621. Epub 2021 Dec 1. Cancer Res. 2022. PMID: 34853072
A NOTCH feed-forward loop drives reprogramming from adrenergic to mesenchymal state in neuroblastoma.
van Groningen T, Akogul N, Westerhout EM, Chan A, Hasselt NE, Zwijnenburg DA, Broekmans M, Stroeken P, Haneveld F, Hooijer GKJ, Savci-Heijink CD, Lakeman A, Volckmann R, van Sluis P, Valentijn LJ, Koster J, Versteeg R, van Nes J. van Groningen T, et al. Nat Commun. 2019 Apr 4;10(1):1530. doi: 10.1038/s41467-019-09470-w. Nat Commun. 2019. PMID: 30948783 Free PMC article.
Therapeutic Strategies for Targeting CDKN2A Loss in Melanoma.
Kreuger IZM, Slieker RC, van Groningen T, van Doorn R. Kreuger IZM, et al. Among authors: van groningen t. J Invest Dermatol. 2023 Jan;143(1):18-25.e1. doi: 10.1016/j.jid.2022.07.016. Epub 2022 Sep 16. J Invest Dermatol. 2023. PMID: 36123181 Free article. Review.